Colon Cancer

我们是谁

  • 7 月 29, 2024
    A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors
  • 8 月 31, 2023
    Phase I Trial of Adagrasib (MRTX849) in Combination With Cetuximab and Irinotecan in Patients With Colorectal Cancer
  • 4 月 5, 2022
    Phase I/II Trial of the Combination of Bintrafusp Alfa (M7824), Entinostat and NHS-IL12 (M9241) in Patients With Advanced Cancer
  • 4 月 5, 2022
    Study of PI3Kinase Inhibition (Copanlisib) and Anti-PD-1 Antibody Nivolumab in Relapsed/Refractory Solid Tumors With Expansions in Mismatch-repair Proficient (MSS) Colorectal Cancer
  • 4 月 5, 2022
    给 HLA-A*11:01 患者注射用识别变异 RAS G12D 变异的小鼠 T 细胞受体转导的外周血淋巴细胞
  • 4 月 5, 2022
    利用 CRISPR 基因工程抑制编码细胞内免疫检查点 CISH 基因的肿瘤浸润淋巴细胞治疗转移性胃肠癌的研究
  • 4 月 5, 2022
    Study of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer
  • 4 月 5, 2022
    给 HLA-A*11:01 患者注射用识别变异 RAS G12V 变异的小鼠 T 细胞受体转导的外周血淋巴细胞